Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-08-25 00:00:00 ET · period of report 2023-08-23 · accession 0001846478-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-25 | 2023-08-23 | ANIP | Gutwerg Ori | SVP, GENERICS | S - Sale+OE | $62.39 | -15.6K | 63.0K | -20% | -$970.9K |
| D | 2023-08-25 | 2023-08-23 | ANIP | Gutwerg Ori | SVP, GENERICS | M - OptEx | $31.49 | +13.5K | 76.5K | +21% | +$425.2K |
| D | 2023-08-25 | 2023-08-23 | ANIP | Gutwerg Ori | SVP, GENERICS | M - OptEx | $31.49 | -13.5K | 13.5K | -50% | -$425.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-23 | S | D | 2,059 | $62.39 | 60,915 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.32 to $62.50, inclusive. |
| 2 | Common | Common Stock | 2023-08-23 | M | A | 13,502 | $31.49 | 76,476 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-23 | S | D | 13,502 | $62.39 | 62,974 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.31 to $62.68, inclusive. |
| 4 | Derivative | Stock Option (right to buy) | 2023-08-23 | M | D | 13,502 | $31.49 | 13,504 | D | $31.49 · — to 2031-02-15 | 13,502 Common Stock | (F3) 25% of the total options vested on each of February 15, 2022 and February 15, 2023. 25% of the total options will vest on each of February 15, 2024 and February 15, 2025. |